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Abstract: Ten novel polyhydroxylated 9,ll-secosterols, 1-10, have been isolated from the New Caledonian sponge 
Euryspongiu sp. and their structures elucidated by spectroscopic studies, selcctive acetylation and reduction, leading to the complete 
assignment of all the NMR signals. Euryspongiols Al-A5 differ in their side chains but have the same 2a,3ß,4a,6ß,11,19 
hexahydroxy-9,ll-secocholestane skeleton. Euryspongiols B 1-B5 are the corresponding 3a epimers. Compounds 1-10 are the most 
highly hydroxylated secosteroids isolated so far, and are the first hydroxylatcd at C4. NaBH4 reduction of the carbonyl group at C-9 
of 1 and 2 is stereospecific, producing the heplahydroxylated secosteroids l a  and 2b with a ß C-9 hydroxyl group. Compounds 1 
and 2 have been found to strongly inhibit the release of histaminc from rat mastocysts. 
INTRODUCTION 
Steroids, as components of all living organisms, have been a frequent subject of marine studies. Apart 
from the large number of novel structures disclosed, interesting biogenetic and synthetic work have been 
described. In the last few years, advances in this field have coincided with advances in the study of water- 
soluble marine natural products. Specifically, there is now a well established methodology for studying the- , 
intact structure of steroid (and terpenoid) saponins. 
The known water-soluble marine steroids are the polyhydroxysteroids found in sponges1 and 
equinoderms2 and the polyhydroxysecosteroids from sponges, soft corals and gorgonians.3 
Among this latter class of compounds, the 9,l l-secosteroids are the most abundant. Structurally, all 9,ll- 
secosteroids have a keto group at C-9 and a side chain like those usually found in "normal" steroids;4 
differences reside in the A-B ring fusion (cisltruns or A5) and the number and position of the hydroxyl (or 
epoxidë) group-s, which are always located on rings A and B. I 1 r i 
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Trans decalin 9,ll-secosteroids have been found in the sponges Aplysilla glacialis5 (glaciasterols A and 
B) and Spongia oj5cinalis6 both trans and As decalin 9,ll-secosteroids in the soft coral Sclerophytum sp;7 and 
A5-secosteroids in the gorgonian Pseudopterogorgia americana3 and the soft coral Sinularia To date, the 
sole cis decalin system reported is herbasterol, found by Faulkner et al. from Dysidea herbacea .lo 
According to the degree and pattern of hydroxylation, the simplest compounds of this class are the 3, l l -  
dihydroxy and the 3,6,1 l-trihydroxy-9,1l-secosteroids.~~6~~ GlaciasterolsS have four oxygenated sites (3,5,6 
and l l ) ~ ,  with hydroxyl groups at C-3 and C-11 and an epoxide bridge at C-5, C-6. Herbasteroll0 which is 
pentahydroxylated at 2,3&,11 and 19, has the highest degree of oxygenation hitherto reported in the secosteroid 
literature. 
RESULTS AND DISCUSSION 
In the course of our investigations on marine invertebrates we have now isolated ten hexahydroxylated 
9,11-secosterols from the polar extracts of a new species of a marine sponge Euryspongia sp. (Porifera, 
Demospongiae, family Dysideidae), which was collected on the coast of New Caledonia and selected for study 
because of the cytotoxicity and strong antihistaminic activity of its extracts. 
The structure of the new compounds which we have named euryspongiols (1-10, Fig. l), were 
elucidated by spectral analysis and chemical transformations. 
The freshly collected sponge (556.30 g) was extracted, defatted and chromatographed to afford a fraction 
containing the secosteroids, which were separated by reversed phase HPLC to yield compounds 1 (30 mg), 2 
(32 mg), 3 (1.5 mg), 4 (1 mg), 5 (7 mg), 6 (17 mg), 7 (5 mg), 8 (1.5 mg), 9 (1.5 mg) and 10 (6 mg). 
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Figure 1. Structures of the 9,11-secosterols from Euryspongia sp. 
These secosteroids can be classified in two series, euryspongiols A (compounds 1-5) and euryspongiols 
- . -. - - B (compounds 6-lo),- according to their stereochemistry at C-3. For the sake of simplicity, their structural 
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features will be presented in accordance with this classification. 
Euryspongiol A l  (1). The molecular formula of the major component 1 was determined by high 
resolution EMS as C27&607 (5 unsaturations). EIMS showed main fragments at mlz 452 corresponding to 
C26H4406 [M-CHzOI+; 434 [M-CHzO-H20]+; 416 [M-CH20-2HzO]+ and 398 [M-CHz0-3HzO]+. The 
presence of an unsaturated CsHl5 steroidal side chain was indicated by an ion at mlz 341 [M-CHzO-C8H15]+. 
Some of the most relevant fragments are shown in Figure 2. 
Negative ion mode FAB MS produced a prominent fragment at mlz 451 [M-H-CHzOI-, while positive ion 
mode FAB MS in a glycerol matrix showed the expected [M+H]+ ion at mlz 483 and also the loss of a molecule 
of water at mlz 465 [M+H-H20]+, loss of five molecules of water at mlz 393 [M+H-5HzO]+, and loss of the 
side chain at mlz 354 [M+H-H20-CsHig]+. 
*I 
i 
Figure 2. Fragments observed in EIMS of compound 1. 
The 13C NMR spectrum of 1 contained signals for all twenty seven carbon atoms. A ketone signal at 6 
215.4 (C-9) and a pair of spzcarbons at 6 138.4 and 6 128.4 (C-22/23) indicated the presence of a carbonyl 
group and a disubstituted double bond, so only three rings (as against four in a normal steroid) are present to 
justify the unsaturation number, suggesting a secosteroid structure. Six resonances between 6 82.8 and 59.2 
supported the existence of six sites with a heteroatom (oxygen) substituent. On the basis of DEPT experiments, 
two of these signals (6 63.9 and 59.2) were assigned to hydroxymethylene carbons and the other four (6 82.8, 
71.1,70.5 and 64.7) to hydroxymethines (see Table 1). 
Due to the polyhydroxylated structure of 1, pyridine-induced deshieldingl' was prominent and the 1H 
NMR pattern varied greatly as compared with the spectrum taken in CD30D (see Table 2). In pyridine-dg, 
compound 1 showed signals for four of the five methyl groups of a C-27 sterol at 6 0.84 (6H, d, H-26/27), 
The singlet that one would expect for the C-19 methyl protons is absent from the spectrum of 1, and 
instead doublets were observed at 6 5.73 and 4.40 ppm (1H each, J = 11.7 Hz) corresponding to an isolated C- 
19 hydroxymethylene group. A second hydroxymethylene group gave rise to signals at 6 4.20 (1H) and 4.10 
(IH) that agree well with the C-11 protons of a 9,ll-secosterol. 
In spite of the infomation provided by the pyridine-induced effects, the overlapping of signals was too 
extensive for complete analysis of the relevant spin systems and identification of signals by 2D correlations. 
However, a combination of the NMR data (COSY and HETCOR) for 1 and various derivatives allowed 
complete signal assignment and stereochemical analysis, as follows. 
The mutually coupled signals observed in the COSY spectrum at 6 4.48 (IH, dd, J = 8.7,4.7 Hz), 3.95 
0.91 (3H, S, H-18), 1.03 (3H, d, H-21). 
? I  
b-' 
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(lH, t, J = 8.7 Hz) and 4.58 (IH, dd, J = 11.2, 8.7 Hz) were taken to correspond to the three axial 
hydroxymethine protons of a 2a,3p,4a-trihydroxysterol. 
Table 1. 13C NMR Spectral data for the secosterols 1, l a  and 7 
Carbon No. 1 6, DEPT la 6, DEPT 7 6, DEW ” 
I 
&%OD) (CD30D) (CD30D) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
1 0  
1 1  
1 2  
1 3  
1 4  
1 5  
1 6  
1 7  
1 8  
19  
2 0  
2 1  
2 2  
23 
24 
25  
26  
27  
35.5, t 
71.1, d 
82.8, d 
70.5, d 
56.3, d 
64.7, d 
41.3, t 
39.7, d 
215.4, s 
56.2, s 
59.2, t 
41.3, t 
46.6, s 
43.1, d 
23.9, t 
26.7, t 
51.0, d 
18.1, q 
63.9, t 
39.7, d 
22.3, q 
138.4, d 
128.4, d 
43.2, t 
29.1, d 
22.1, q, 
22.7, q 
37.0, t 
70.8, d 
83.4b, d 
70.6, d 
64.8, d 
41.3a, t 
39.7, d 
83.2b, d 
59.1, t 
47.0, s 
22.1, t 
27.3, t 
18.6, q 
63.6, t 
40.0a, d 
22.7, q 
138.6, d 
128.3, d 
29.7, d 
22.2, q 
22.2, q 
30.6, t 
68.4, d 
74.3, d 
68.2, d 
50.2, d 
65.1, d 
41.4, t 
39.9, d 
215.0, s 
56.1, s 
59.2, t 
41.2, t 
46.7, s 
42.9, d 
23.8, t 
26.8, t 
50.8, d 
17.8, q 
63.5, t 
35.6, d 
19.8, q 
36.7, t 
25.6, t 
40.6, t 
e 29.1,d 
22.9, q 
22.9, q 
ab Assignments may be interchanged 
The HETCOR spectrum showed correlation of the peak at 6 82.8 attributed to C-3 with the triplet at 3.95 
(H-3) and correlation of the signals at 671.1 and 70.5 with the multiplets at 6 4.48 and 4.58 assigned to H-2 
and H-4. The remaining signal at 6 5.05 (1H) was then attributed to an equatorial hydroxymethine proton aH-6 
by analysis of the C-4/C-5/C-6 spin system (vide infra). 8, 1 1  
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Table 2. 1H NMR Spectral data for the secosterol 1, la and 7 
Proton No. 16, mult, J(Hz) 1 6, mult, J(Hz) la  6, mult, J(Hz) 7 6, mult, J(Hz) 
(C5D5N) (CD3OD) (CD30D) (CD3OD) 
la  
lß 
2 
3 
4 
5 
6 
7 a  
7ß 
8 
9 
1 1  
11' 
1 2  
1 4  
1 5  
16 
17 
18 
19  
19' 
20  
2 1  
2 2  
23  
24  
25  
26  
k.1 27 
3 
2.20 
3.12 dd, 13.3,4.7 
4.48 dd, 8.7,4.7, 
3.95 t, 8.7 
4.58 dd, 11.2, 8.7 
2.05 dd, 11.2,2.7 
5.05 
2.45 
1.70 
4.20 
4.10 
4.20 
2.00 
3.00 
1.55 
1.48 
1.70 
0.91 s 
4.40 d, 11.7 
5.73 d, 11.7 
2.10 
1.03 d, 6.7 
5.28 
5.28 
1.80 
1.50 
0.84 d, 6.6 
0.84 d, 6.6 
1.45 
2.34 dd, 13.7,4.8 
3.69 
3.10 t, 8.9 
3.64 
1.49 dd, 11.3, 2.3 
4.32 dd, 2.4, 2.4 
2.32 
1.56 
3.46 ddd, 13.6,4.6,4.1 
3.66 
3.66 
1.64 
2.49 
1.37 
1.36 
1.60 
0.81 s 
3.70 
4.85 
2.24 
1.07 d, 6.8 
5.36 
5.36 
1.88 dd, 9.4.3.3 
1.53 
0.91" d, 6.6 
0.89" d, 6.6 
0.99 t, 12.7 
2.65 dd, 12.7.4.6 
3.66 
3.14 t, 8.9 
3.60 
1.20 dd, 11.3.2.3 
4.15 dd, 2.4, 2.4 
1.92 
1.29 
1.65 
2.98 d, 10.8 
3.70 
3.70 
1.78 
2.32 
1.48 
1.44 
1.59 
0.82 s 
3.64 d, 12.1 
4:43 d, 12.1 
2.16 
1.06 d, 6.8 
5.33 
, 5.33 
1.86 
1.61 
0.87 d, 6.6 
0.87 d, 6.6 
1 .a 
2.00 dd, 13.2,4.15 
3.82 
3.93 dd, 2.9, 2.4 
3.80 dd, 11.4, 2.4 
1.86 dd, 11.4, 2.4 
4.28 dd, 2.4,2.4 
2.28 
1.52 
3.47 ddd, 13.2,4.6,4.1 
3.60 
3.60 
1.67 
2.47 
1.37 
1.37 
1.53 
0.77 s 
3.70 d, 11.5 
4.78 d, 11.5 
1.42 
1.00 d, 6.4 
1.10 
1.54 
0.87 d, 6.7 
0.87 d, 6.7 
a Assignments may be interchanged 
The coupling constants corresponding to H-5 (8 2.05, dd, J = 11.2, 2.7 Hz) are indicative of its trans 
diaxial relationship with H-4 and axial-equatorial relationship with H-6. The trans A/E3 ring fusion in 1 can be 
deduced by comparison of the C-13 chemical shifts, (especially that of the C-19 hydroxymethyl group) with the 
calculated values for cis and trans decalines. Addition of the standard -OH group a effect (+49 ppm) to the 
chemical shift of the methyl group in trans (15.7 ppm) and cis (28.2 ppm) 9-methyldecalin predicts shifts of 
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Irradiated proton 
H-3 
H-9 
H-5 
64.7 ppm and 77.2 ppm for the corresponding truns and cis 9-hydroxymethyl decalines respectively; thus the 
experimental value of 63.9 ppm for 1 clearly implies truns fusion.l2 Furthermore, direct experimental evidence 
of trans fusion came from a NOE experiment run on derivative la (Fig. 3), which showed NOEs among H-5 
(ax) and H-3 (ax) and H-9 (ax) and H-7 (ax) (Table 3). 
l a  R=OH R'=OH R = a  
l b  R=OAc R'=OAc R = a  
2a R=OAc R'=O R = b  
i 
4 
R 
2b R=OAc R'=OH R = b  
2~ R=OAc R'=OAc R = b  
H 
Figure 3 
NOE 
----- ---__ ----- H-5 H-la  
----- ----- H-14 H-5 H-la 
H-6 H-3 H-9 H-7a H-la 
The signal due to H-8 is especially difficult to identify in this type of secosteroids, not only because of the 
complexity of the spectra and the rotation around the C-8/C-14 bond, but also because these compounds are not 
structurally stable under basic treatment,ll which in consequence cannot be used to simplify the spectra by 
deuterium exchange. In CgDgN, and due to overlapping, the coupling constants of H-8 with H-7/7' and H-14 
could not be measured. In CD30D, they could be obtained (J = 13.6, 4.6, 4.1 Hz), and were assigned taking 
into account the trans diaxial relationship between H-8 and H-9 (10.8 Hz in la). Thus H-8 lies in axial 
position, with coupling constants of 13.6 Hz with aH-7 (ax) and 4.6 and 4.1 Hz with /3H-7 (eq) and H-14 
respectively. 
Comparison of the 1H and 13C NMR data for the side chain with those of the literature13 suggested the 
presence of an E A22 double bond in 1. 
Taken together, the above evidence indicates that compound 1, named euryspongiol A l ,  i s  
2a,3/3,4~~,6/3,11,19-hexahydroxy-9,11 secocholest-22(E)-en-9-one. 
Table 3. NOEs observed in compound l a  
Euryspongiols A2-AS (2-5). The molecular formula of compound 2, euryspongiol A2, was deduced 
as C27Q807 from HREIMS, FAB MS (negative ion mode) and 13C NMR/DEPT spectral data, I3C and lH 
chemical shift values in compound 2 were virtually identical to those of compound 1, the absence of the double 
bond being the only difference and suggesting that 2 is the saturated counterpart of 1. An EIMS fragment at mlz 
323 [M-CH~O-H~O-CEH~~]+  confirmed the presence of a saturated C8H1-j side chain in 2. The 13C NMR 
spectra of 3 and 4, euryspongiols A3 and A4 respectively, contained signals for twenty eight carbon atoms, 
I .  
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while compound 5, euryspongiol A5, had twenty six. Comparison of their 'H and 13C-NMR data with those 
of 1 and 2 indicate that all the secosteroids of the A series share the same skeleton, substitution pattern and 
regio; and stereochemistry, and differ only in their side chain structures. 
Both 3 and 4 have the same molecular formula, C28H4807, showing the presence of a disubstituted 
double bond (6 137.7, C-23; 6 135.2, C-22) and one more methyl group than in 1 and 2 (3, 6 0.94, d, J = 6.9 
Hz, Me-28; 4, 6 0.96, d, J = 6.9 Hz, Me-28). Both these features are located in their side chains, and make 
them (22E)-24-methyl- A22-sterols.14 Under (-)FAB MS, both compounds had the same [M-HI- ion (mlz 495) 
and the same fragmentation pattern, suggesting that these two isomers are epimers at C-24. Their EMS showed 
ions at mlz 466 [M-CH20]+ and mlz 341 [M-CHzO-C9H17]+, confirming the presence of the unsaturated 
C9H17 side chains. Their stereochemistry at (2-24 was deduced by comparison with known 24R and 24s 
epimers of (22E)-24-methyl- AZ2-sterols, using the proton chemical shift of the Me-2 1 protons as diagnostic 
signal (the 24R epimer signal lies downfield of the 24s signaL14,15 Since Me-21 resonates at 6 1.06 (d, J = 6.9 
Hz) in 3 at 6 1.07 (d, J = 6.8 Hz) in 4, compound 3 is 2a,3~,4a,6p,l1,19-hexahydroxy-9,1l-secocholest- 
(22E,24S)-24-methyl-en-9-one and compound 4 2a,3p,4a,6p, 1 1119-hexahydroxy-9, 1 l-secocholest- 
(22E,24R)-24-methyl-en-g-one. 
Secosterol 5, euryspongiol A5, has the molecular formula C26H4407, corresponding to a norsecosteroid. 
A (+)FAB MS experiment in a NaCl+glycerol matrix produced an [M+Na]+ ion at mlz 491 and a fragment at 
mlz 394 [M+Na-C7H13]+ due the loss of the unsaturated C7H13 side chain. The lH NMR spectrum of 5 
contained resonances that could be assigned to one tertiary methyl group (6 0.78, s, 3H, Me-18) and three 
secondary methyl groups (60.96, 6H, d, J = 6.7 Hz, Me-25/26 and 1.03, 3H, d, J = 6.8 Hz, Me-21). The I3C 
NMR spectrum showed two sp2 carbons at 6 136.0 and 134.0 ppm identified as C-22 and C-23. These data, 
together with comparison with the literature,l6 indicate that 5 is 2a,3P,4a,6/3,11,19-hexahydroxy-9,11- 
seconorcholest-(22E)-en-9-one. 
3 
Euryspongiols Bl-B5 (6-10). Comparison of their spectral data showed that secosteroids 6-10 
(euryspongiols B) are the C-3 epimers of secosteroids 1-5 (euryspongiols A). Their structures were determined 
by exhaustive spectroscopic analysis, which includes HMBC, HMQC, COSY and TOCSY experiments on 7 
and 8. 
The 'H NMR data of 7, euryspongiol B2, showed important A-ring differences from secosteroids 1-5 in 
the 3-4 ppm region. The l3C NMR spectrum confirmed these differences, the hydroxylated carbons now 
resonating at 674.3, 68.4, 68.2, 65.1, 63.5 and 59.2. HMQC and HMQC experiments allowed assignment of 
all the carbons with their hydrogens (see Tables 1 and 2). 'H NMR COSY and TOCSY experiments were used 
to analyse all the relevant spin systems and to measure the vicinal coupling constants (J) at the three 
hydroxylated carbons in ring A: H-4 (6 3.80, dd, J = 11.4 and 2.4 Hz) was shown to have trans-diaxial 
coupling to H-5 and an ax-eq relationship with H-3 (63.93 dd, J = 2.9 and 2.4 Hz), which in turn is coupled to 
H-2 at 3.82 ppm with a small constant (J = 2.9 Hz) indicative of an ax-eq orientation. Thus both H-2 and H-4 
are axial, while H-3 is equatorial and H-5 is axial. 
The trans ring fusion of the A/B rings was deduced as before by comparison with models and by 
ROESY. Figure 4 shows relevant NOES that corroborated the above stereochemical results. 
Thus compound 7, named euryspongiol B2 is 2a,3a,4a,6j3,11,19-hexahydroxy-9,1 l-secocholestan-9- 
one, and compounds 6, 8, 9 and 10 are the C-3 epimers of 1, 3, 4 and 5 respectively. Compound 6, 
euryspongiol BI is 2a,3a,4a,6P,11,19-hexahydroxy-9,1 l-secocholest-(22E)-en-9-one. Compound 8, 
q. ' 
ci 
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euryspongiol B3 is 2a,3a,4a,6P,1 1,19-hexahydroxy-9,1 l-secocholest-(22E,24S)-24-methyl-en-9-one. 
Compound 9, euryspongiol B4 is 2a,3a,4a,6b, 11,19-hexahydroxy-9,1 l-secocholest-(22E,24R)-24-methyl- 
en-9-one. Compound 10, euryspongiol B5 is 2a,3a,4a,6p, 11,19-hexahydroxy-9,1 l-seconorcholest-(22E)- 
en-9-one. , 
I- 
d 
Figure 4. Selected NOEs for compound 7. 
Conformation and absolute stereochemistry. In addition to coupling constant values, ROESY 
experiments gave information on rotation about the C-8/C-14 bond and the presence of a conformational 
preference. The coupling constant between H-8 and H-14 about 4 Hz, (see Table 2) suggested a gauche-like 
arrangement of these’hydrogens, and this was confirmed by the ROESY spectrum. Strong NOEs were 
observed between H-8 and H-14; H-8 and H-7@ eq); H-14 and H-7(4, eq); and between Me-18 andH-7(ß, 
es). Thus, the preferred conformation is as depicted in Figure 5. 
Molecular Mechanics calculations (MM2 Force Field) confirmed the existence of an energy minimum 
when the dihedral angle between H-8 and H-14 was 50°, in which conformation their calculated coupling 
constant was 4.55 Hz. MM2 calculations also confirmed the dihedral angles and general geometry of the A/B 
decalone system. 
R1 = Side chain 
Ra = -CH 2-CH2-OH 
Ri 
R3 = A ring 
OH Ra 
Figure 5 
Finally, the absolute stereochemistry of compounds 1-10 was investigated by circular dichroism 
measurements. The CD spectrum of 2 showed a negative Cotton effect in the 295 nm carbonyl absorption 
region. This band coincides with the one observed for similar 9,ll-secosterols with an equatorial substituent at 
C(8),10 which have the configuration shown in the Figure 1. As compounds 1-10 all had very similar negative 
optical rotation values, it can safely be concluded that they all belong to the enantiomeric series shown in the 
figures. 
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Hydride reduction of the 9 keto group of 9,ll-secosteroids. The reduction of the C-9 
carbonyl group of 1 with NaB%/MeOH yielded exclusively the heptahydroxylated 9,l I-secosteroid la  (6 
2.98, d, J = 10.8 Hz, H-ga), which was further transformed into hepta-acetate lb.  The reduction reaction was 
shown to be stereospecific, giving exclusively the p C-9 equatorial alcohol. This result is noteworthy and rather 
unexpected because no intramolecular assistance by any of the hydroxyl groups seems to occur in spite of the 
apparently favourable spatial location of some of them (notably the secondary axial hydroxyl at C-6 and the 
primary OH at C-lg)(Figure 6). To get further insight into this behaviour, we proceeded to transform the -OH 
groups into non-hydroxyl groups before reduction. Secosteroid 2 was acetylated to the keto-hexa-acetate 2a, 
and the keto group was then reduced with NaB&/MeOH to afford 2b (6 3.12, d, J = 10.6 Hz, H-ga), which 
was further acetylated to 2c. Changing the hydroxyl groups to acetyl groups was not observed to influence the 
stereoselectivity of the process. 
"he formation of the 9pol can be explained in terms of the mechanism suggested by Wigfield,17 in which 
the transition state includes one molecule of solvent alcohol, one molecule of alkoxide, one borohydride ion and 
the ketone, with the borohydride attacking the carbonyl carbon at an angle of 126' and not at = 90". In this long 
acyclic transition state, p attack (leading to the 9n-01) would be impeded by interactions between the 
borohydride ion and both the axial 19-CHzOH and, more severely, the axial 6p-01 (Fig. 7). However, a attack, 
which yields the 9p-01, lacks similar impediments. 
T 
7 
ß attack 
). 
Figure 6 
. . 
a attack 
Figure 7 
Antihistaminic activity. Euryspongiols 1 and 2 were tested for in vitro antiallergic activity by non 
immunological stimulus on rat mast cells. We used as chemical inducer for this assay a low molecular weight 
mixed polymer of N-Methyl-p-methoxifenetilamine cross linked with formaldehyde, marketted as compound 
48/80@ and considered the prototype of polycations that release histamine.'X Compounds 1 and 2 were found to 
reduce the release of histamine induced on rat mast cells by the polymer 48/80 to about two thirds (26 %) and one 
half (15 %) respectively of the amount released by action of the control 48/80 (35 %). Similar values of 
inhibition of histamine release, were observed when GRF (growth releasing factor ) was used as stimulus instead 
of the polymer 48/80. 
Furthermore, the response of the rat mast cells to 1 and 2 is dose-dependent, principally in the case of 1 
(Fig 8). We found also that 1 and 2 act as inhibitors only if there is a preincubation time before the stimulus is 
added to the cells. Simultaneous addition of the stimulus and the chemical showed no inhibitory effect. 
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The similarity of action of 1 and 2 with that of disodium cromoglycate (DSCG),19 a well known 
antihistaminic agent, suggest a common mode of action. 
CONCLUSIONS 
The genus Euryspongia is known to be an important source of furan and pyran-based terpenoids but this 
is the first report of secosteroids in that genus. Structurally, euryspogiols A (1-5) and euryspongiols B (6-10) 
constitute two series epimeric at C-3 and represent the most highly hydroxylated secosterols isolated so far and 
the fiist hydroxylated at C-4. The use of 1 as a model for the study of the stereoselective hydride reduction of 
the carbonyl group is noteworthy due to the high number of hydroxylic groups and their location to produce 
intramolecular assistence. 
The antihistaminic activity of these compounds is interesting because it might be an indication of their 
potential use as antiallergic and in the treatment of asthma. Certain polyhydroxylated steroids have been recently 
found20 to be strong inhibitors of histamine release induced by anti-IgE. The structural analogy of those 
compounds with euryspongiols, may indicate some pharmacological similarity in the mechanism of action. 
EXPERIMENTAL SECTION 
General: NMR spectra were recorded on a Bruker WM-250 and a Varian XL500; chemical shifts are 
reported in 6units relative to tetramethylsilane (6= O) as internal standmd, with CgDgN and CD3OD as solvents; 
J values are given in Hz. 1H NMR and *3C NMR assignments were made using 2D COSY, 2D HETCOR, 
DEPT, TOCSY, ROESY, HMBC and HMQC sequences. EIMS were obtained at 70 eV on a Hewlett-Packard 
HP 59970 MS mass spectrometer. High resolution mass spectra and FAB MS (positive and negative ion 
modes) were recorded on a KRATOS MS 50 spectrometer using a sample dissolved in a glycerol matrix. 
Infrared spectra were recorded on a Perkin-Elmer 1420 spectrophotometer. Optical rotations were measured'on 
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a JASCO DIP-370 digital polarimeter. Circular dichroism spectra were recorded on a Jobin-Ivon instrument in 
absolute MeOH. Column chromatography was performed on Amberlite XAD-2 from Sigma (20-60 mesh) and 
Sephadex LH-20 (20-100 mm). Thin layer chromatography (TLC) analyses were performed on Merck GF-254 
precoated silicagel. Reversed phase HPLC was performed with a Waters Associates 590 pump, a pBondapak 
C1g column (7.8 mm x 30 cm) and a differential refractometer as detector. Compound 48/80 was purchased 
from Sigma Chemical Co, 
Eluents: compounds 1,2 and 7,7:3 MeOH/H2O at 3 mL. min -1; compound 5,7:3 MeOH/H20 at 2 mL,. 
min -1; compounds 3,4,6,8,9 and l(i,6:4 MeOH/H2O at 4 mL.min -1. 
I 
Collection and extraction of the sponge: Euryspongiu sp. (reference R1225), was collected by 
divers using scuba from St. 184, Point Bovis, New Caledonia on 3/12/1979 at a depth of 22 m on coral 
abutting fine sand. Other sponges and soft coral were in association. A voucher specimen will be deposited in 
the Museum of Natural History, Paris and in Museum Orstom in Nouméa. 
The specimen is 10 cm high, 15 cm wide, thrown in to low lobes along the crest of wich large oscules lie 
flush with the surface. The colour is a brilliant lilac purple (Munse11 @/6) mottled with whitish conules which 
mark the point of intersection of primary fibres with the translucent, finely reticulated pinacoderm. The skeleton 
is a strong reticulum in which the primary, ascending fibres are clear of debris but contain scattered bacterial- 
type particles. The secondary connecting fibres form an irregular, relatively dense reticulum. The choanocyte 
chambers are large, oval and eurypylous. The sponge, given these characteristics, falls into the genus 
Euryspongiu (Family Dysideiidae, Order Dictyoceratida) and is distinguished from other members of that genus 
in colour, and in the peculiar nature of the coring material in the fibres. Should subsequent electron microscopy 
study on appropriately fixed material confirm the nature of the inclusions, it could be that a new genus within 
the Family Dysideiidae will have to be established for the species. A full description will be included in a 
forthcoming publication on the Dictyoceratida of New Caledonia. 
The freshly collected sponge was cut into pieces and extracted at room temperature with methanol. The 
solvent was removed from the methanolic extracts by evaporation in vacuo, and the residue was partitioned 
successively between hexane and 10 % aqueous methanol, between ClzCHz and 20 % aqueous methanol, and 
between n-BuOH and 40 % aqueous methanol; evaporation of the solvents gave a hexane extract (9.3 g), a 
C12CH2 extract (9.9 g) and an n-BuOH extract (5.0 g). The n-BuOH extract was added to a column of 
Amberlite XAD-2, and the column was washed with H20 (3L at 2 mL.min-1) and then eluted with MeOH (2L 
at IO mL.min-1). 
The MeOH eluates were concentrated in vacuo to give a residue (2.2 g) that was chromatographed on a 
Sephadex LH-20 column eluted with 2:1 MeOH/HzO. Fractions of 10 mL each were collected and analysed by 
TLC on Si02 in 12:3:5 n-BuOH/AcOH/HzO. 
Fractions D (208 mg) and E (125 mg), which contained the secosterols, were separated by 
semipreparative reversed phase HPLC on a ci8 p-Bondapak.column, eluted with MeOH/H20. This afforded 
pure samples of 1 (30 mg, Rt 44.01 min), 2 (32 mg, Rt 70.00 min), 3 (1.5 mg, Rt 120.11 min), 4 (1 mg, Rt 
120.90 min), 5 (7 mg, Rt 30.00 min), 6 (17 mg, Rt 60.37 min), 7 (5 mg, Rt 60.22 min), 8 (1.5 mg,<Rt 
120.00 min), 9 (1.5 mg, Rt 120.50 min) and 10 (6 mg, RL 46.00 min). 
y 
i 
Euryspongiol A l  (1): (30 mg); [(rIz1~ -42" (c 0.001, MeOH); IR spectrum: um,,(KBr dis) 3450 (br), 
2950,1700 cm-1; 1H NMR (CD30D, CgDgN, 250 Mz) see Table 2; I3C NMR (CD30D, 250 Mz) see Table 1; 
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HR ELMS: obsd 482.3217, calcd for C27a607 482.3243; EIMS mlz (%) 482 (l), 452 (4), 434 (3), 416 (2), 
408 (2), 390 (2), 299 (12), 281 (7), 218 (5), 147 (S), 125 (76), 67 (34), 54 (100 rel); FAB MS (+, glycerol 
matrix) m/z 483, 465, 393, 354,316, 224; FAB MS (-, glycerol matrix) mlz 451, 387, 275, 257, 183, 127, 
91. 
Euryspongiol A2 (2): (32 mg); [a ]21~ -22' (c 0.001, MeOH); CD (MeOH) (e)295 - 6796'; UV f m a x  
(MeOH) 208 nm; HR EIMS: obsd 484.3419, calcd for C27&807 484.3399; EIMS mlz (%) 484 [M+, 11,454 E 
[M-CHzO', 11,436 [M-CH20-H20+, 53,418 [M-CH20-2H20+, 31,410 [M-CH2O-C3H8+, 11,400 [M- 
CH20-3H20+, 11,382 [M-CH20-4H20+, 11,364 [M-CH20-5H20+, 11,323 [M-CH20-H20-C8H17+, 21; 
FAB MS (-, glycerol matrix) m/z:  483, 465, 453, 433, 386, 350, 325, 311, 273, 243, 219, 181, 165, 151, 
H-7P), 2.31 (lH, m, H-la), 2.51 (lH, H-74, 3.34 (lH, dd, J = 13.2, 4.7 Hz, H-I@), 3.97 (lH, t, J = 8.8 
Hz, H-34,  4.23 (lH, H-8), 4.44 (lH, d, J = 11.2 Hz, H-19), 4.58 (lH, m, H-2a), 4.62 (lH, m, H-4a), 
21), 22Sb (C-26), 22.7b (C-26), 23.0 (C-15), 24.5 (C-23), 26.1 (C-16), 27.9 (C-25), 34.5 (C-20), 35.P (C- 
121, 97, 93; 'H NMR (CsDsN, 250 Mz) 6 0.91 (3H, S, H-18), 0.98 (3H, d, J = 6.4 Hz, 8-21), 1.74 (lH, 
5.13 (lH, S, H-6/3), 5.78 (lH, d, J = 11.2 Hz, H-11'); '3C NMR (CgDgN, 250 Mz) 6 17.4 (C-l8), 19.4 (C- 
22), 35.6a (C-l), 38.7 (C-8), 39.5 (C-24), 41.1 (C-12), 41.9 (C-14), 42.0 (C-7), 45.9 (C-l3), 49.7 (C-17), 
55.9 (C-IO), 56.3 (C-3, 58.1 (C-ll), 63.7 (C-19), 64.0 (C-6), 70.1 (C-4), 70.7 (C-2), 83.2 (C-3), 215.4 (C- 
9). 
Euryspongiol A3 (3): (1.5 mg); HR EIMS obsd 496.3401, calcd for C2gH4g07 496.3400; EIMS mlz 
(%) 496 [M+, 1],4661[M-CH20+, 71; FAB MS (-, glycerol matrix) mlz 495 [M-HI-; 1H NMR (CD30D, 250 
J = 6.9 Hz, H-21), 1.34 (2H, m, H-16), 1.36 (2H, m, H-15), 1.46 (IH, H-la), 1.49 (lH, H-5), 1.57 (lH, 
Mz) 6 0.79 (3H, S, H-18), 0.87 (6H, d, J = 6.9 Hz, H-26, 27), 0.94 (3H, d, J = 6.9 Hz, H-28), 1.06 (3H, d, 
H-7/3), 2.20 (lH, H-~cz), 2.34 (lH, dd, J = 13.6, 4.9 Hz, H-lj), 2.49 (lH, H-14), 3.07 (lH, t, J = 9.0 Hz, 
H-3), 3.47 (lH, H-8), 3.62 (lH, H-4), 3.68 (2H, H-ll), 3.68 (lH, d, J = 11.5 Hz, H-19), 3.70 (lH, H-2), 
4.30 (lH, H-6), 4.85 (lH, d, J = 11.5 Hz, H-19), 5.25 (2H, m, H-22, 23); 13C NMR (CD30D, 250 Mz) 6 
18.1 (C-lS), 19.6 (C-28), 23.5 (C-21), 23.9 (C-15), 24.2 (C-26, 27), 26.7 (C-16), 35.5 (C-l), 35.7 (C-25), 
39.7 (C-8), 41.3 (C-7), 41.3 (C-12), 41.7 (C-20), 43.1 (C-14), 45.8 (C-24), 46.6 (C-13), 51.0 (C-17), 56.2 
(C-IO), 56.3 ((2-3, 59.2 (C-11), 63.9 (C-19), 64.7 (C-6), 70.5 (C-4), 71.1 (C-2), 82.8 (C-3), 135.2 (C-22), 
137.7 (C-23), 215.4 (C-9). 
Euryspongiol A4 (4): (1 mg); HR EIMS obsd 496.3401, calcd for C28H4807 496.3400; EIMS m/z 
(%) 496 [M+, 11,466 [M-CHzO+, 71; FAB MS (-, glycerol matrix) mlz 495 [M-HI-; IH NMR (CD30D, 250 
Mz) 60.81 (3H, S, H-18), 0.89 (6H, d, J = 6.6 Hz, H-26, 27), 0.96 (3H, d, J = 6.9 Hz, H-28), 1.07 (3H, d, 
f 
Q 
J = 6.8 Hz, H-21), 1.36 (2H, m, H-16), 1.37 (2H, m, H-15), 1.46 (lH, H-la), 1.49 (lH, H-5), 1.58 (IH, 
(lH, t, J = 8.9 Hz, H-3), 3.46 (lH, H-8), 3.64 (IH, H-4), 3.64 (2H, m, H-11), 3.66 (lH, H-2), 3.75 (lH, 
d, J = 11.5 Hz, H-19), 4.33 (lH, H-6), 4.85 (lH, d, J = 11.5 Hz, H-19), 5.20 (2H, m, H-22, 23); 13C NMR 
H-7/3), 1.67 (2H, H-12), 2.24 (lH, H-7a), 2.32 (lH, dd, J = 13.6, 4.8 Hz, H-lj) ,  2.47 (lH, H-14), 3.10 
(CD30D, 250 Mz) 6 18.1 (C-IS), 19.6 (C-28), 23.5 (C-21), 23.9 (C-15), 24.2 ((2-26, 27), 26.7 (C-16), 35.5 
(C-l), 35.7 (C-25), 39.7 (C-8, C-20), 41.3 (C-7), 41.3 (C-12), 43.1 (C-14), 45.8 (C-24), 46.6 (C-13), 51.0 
(C-17), 56.2 (C-lo), 56.3 (C-5), 59.2 (C-11), 63.9 (C-19), 64.7 (C-6), 70.5 (C-4), 71.1 (C-2), 82.8 (C-3), 
135.2 (C-22), 137.7 (C-23), 215.4 (C-9). 
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Euryspongiol A5 (5): (7 mg); [aIz1D -48" (e 0.0001, MeOH); HR EIMS: obsd 468.3090, calcd for 
C2&407 468.3087; FAB MS (+, NaCl+glycerol matrix) mlz 491 [M+Na]*, 394 [M+Na-C7H13]+; 'H NMR 
21), 1.34 (2H, m, H-16.), 1.38 (2H, m, H-15), 1.45 (lH, H-la), 1.45 (lH, dd, J = 11.7, 2.5 Hz, H-5), 1.53 
(lH, H-7p), 1.64 (2H, m, H-12), 2.21 (IH, H-24), 2.22 (lH, H-7a), 2.30 (lH, dd, J = 13.8, 5.1 Hz, H-lp), 
2.44 (IH, H-14), 3.07 (IH, t, J = 9.0 Hz, H-3), 3.46 (IH, H-8), 3.61 (2H, m, H-Il), 3.65 (IH, H-4), 3.69 
19), 5.30 (2H, m, H-22, 23); 13C NMR (CD3OD, 250 Mz) 6 18.1 (C-18), 22.2 (C-21), 23.9 (C-15), 26.3 (C- 
(CD30D, 250 Mz) 6 0.78 (3H, S, H-18), 0.96 (6H, d, J = 6.7 Hz, H-25, 26), 1.03 (3H, d, J = 6.8 Hz, H- 
i 
(IH, H-2), 3.72 (IH, d, J = 11.6 Hz, H-19), 4.31 (lH, d, J = 2.5 Hz, H-6), 4.87 (lH, d, J = 11.8 Hz, H- 
16), 32.3 (C-24), 35.5 (C-1), 39.4 (C-20), 39.8 (C-8), 41.3 (C-7,12), 43.1 (C-14), 46.7 (C-13), 51.0 (C- 
17), 56.2 (C-lo), 56.3 (C-5), 59.2 (C-ll), 64.0 (C-19), 64.7 (C-6), 70.5 (C-4), 71.1 (C-2), 82.8 (C-3), 
134.0 (C-23), 136.0 (C-22), 214.8 (C-9). 
Euryspongiol B1 (6): (17 mg); [ a I 2 1 ~  -39" (e 0.003, MeOH); HR EIMS: obsd 482.3239, calcd for 
1.10 (3H, d, J = 6.8 Hz, H-21), 1.32 (2H, m, H-16), 1.34 (2H, m, H-15), 1.55 (lH, H-25), 1.55 (lH, H- 
7p), 1.60 (lH, H-17), 1.63 (2H, H-12), 1.66 (lH, H-la), 1.75 (lH, H-5), 1.88 (lH, dd, J = 8.9, 3.0 Hz, H- 
24), 2.01 (lH, dd, J = 13.6, 4.5 Hz, H-ID), 2.26 (lH, H-20), 2.26 (lH, H-7a), 2.55 (lH, H-14), 3.47 (IH, 
C27H4607 482.3243; 'H NMR (CD30D, 500 Mz) 6 0.84 (3H, S, H-ls), 0.91 (6H, d, J = 6.6 Hz, H-26, 27), 
H-8), 3.65 (2H, H-11), 3.78 (lH, d, J = 12.8 Hz, H-19), 3.84 (IH, dd, J = 11.3, 2.6 Hz, H-4), 3.89 (IH, 
dd, J = 11.6, 4.5 Hz, H-2), 3.99 (lH, dd, J = 4.5, 2.7 Hz, H-3), 4.33 (lH, d, J = 2.8 Hz, H-6), 4.86 (lH, 
d, J = 11.3 Hz, H-19), 5.36 (2H, m, H-22, 23); 13C NMR (CD30D, 500 Mz) 6 18.1 (C-18), 22.3 (C-21), 
22.7 (C-26, 27), 24.0 (C-15), 26.7 (C-16), 29.7 (C-25), 30.6 (C-l), 39.7 (C-8), 40.0 (C-20), 41.3 (C-12), 
41.5 (C-7), 43.1 (C-14), 43.2 (C-24), 46.6 (C-13), 51.0 (C-17), 56.2 (C-lo), 59.2 (C-11), 63.5 (C-19), 65.1 
(C-6), 68.2 (C-4), 68.4 (C-2), 74.3 (C-3), 128.4 (C-23), 138.4 (C-22), 216.8 (C-9). 
Euryspongiol B2 (7): (5 mg); [0112*~ -50" (e 0.0006, MeOH); HR EIMS obsd 484.3403, calcd for 
C27H4807 484.3400; EIMS (%)m/z 484 [M+, 11,454 [M-CHzO+, 51,436 [M-CH20-H20+, 231,418 [M- 
CH20-2H20+, 51, 400 [M-CH20-3H20+, 41, 305 [M-CHZO-H~O-C~H~~+,  81; FAB MS (+, NaCl+glycerol 
matrix) mlz 507 [M+Na]+, 394 [M+Na-CxH17]+; 'H NMR (CD30D, 500 Mz) 6 see table 2; 13C NMR 
(CD3OD, 500 Mz) 6 see table 1. - 
Euryspongiol B3 (8): (1.5 mg); HR EIMS: obsd 496.3405, calcd for C2xH4807 496.3400; EIMS m/z 
(%) 496 [M+, 11 466 [M-CHzO+, 61, 305 [ M - C H ~ O - ~ H Z O - C ~ H ~ ~ + ,  81; FAB MS (+, NaCl+KCl+glycerol 
matrix) mlz 535 [M+K]+, 519 [M+Na]*, 371 [M-CgH17]+; 'H NMR (CD30D, 500 Mz) 60.79 (3H, s, H- 
(2H, m, H-16), 1.51 (lH, H-7D), 1.52 (2H, m, H-15), 1.58 (2H, H-12),1.64 (lH, H-25), 1.65 (lH, H-la), 
H-74,  2.48 (IH, H-14), 3.48 (lH, H-8), 3.59 (2H, H-Il), 3.72 (lH, d, J = 11.5 Hz, H-19), 3.80 (lH, dd, 
4 
d 18), 0.89 (6H, d, J = 7.0 Hz, H-26, 27), 0.93 (3H, d, J = 7 Hz, H-28), 1.05 (3H, d, J = 7.0 Hz, H-21), 1.38 
1.85 (lH, dd, J = 11.9, 3.0 Hz, H-5), 2.00 (lH, dd, J = 13.5, 3.9, Hz, H-lp), 2.18 (lH, H-20), 2.23 (IH, 
J = 11.9, 3.0 Hz, H-4), 3.82 (ZH, H-2), 3.93 (lH, t, J = 3.0 Hz, H-3), 4.28 (lH, H-6), 4.85 (lH, d, J = 
11.5 Hz, H-19), 5.24 (2H, dd, J = 15.0, 7.5 Hz, H-22), 5.28 (lH, d, J = 15.0, 8.0 Hz, H-23); 13C NMR 
(CD30D, 500 Mz) 6 19.0 (C-18), 19.6 (C-28), 23.5 (C-21), 24.2 ((2-26, U ) ,  25.1 (C-15), 28.1 (C-16), 31.7 
(C-l), 35.7 (C-25), 41.0 (C-8), 41.1 (C-20), 42.2 (C-12), 42.8 (C-7), 44.1 (C-14), 45.8 (C-24), 47.9 (C- 
131, 51.3 ('2-9, 57.3 (C-lo), 60.5 (C-ll), 64.5 (C-19), 66.2 (C-6), 69.6 (C-4), 69.6 (C-2), 75.4 (C-3), 
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135.2 (C-22), 137.7 (C-23), 215.4 (C-9). 
Euryspongiol B4 (9): (1.5 mg); HR EIMS: obsd 496.3405, calcd for C2gH4g07 496.3400; EIMS mlz 
(%) 496 [M+, 11 466 [M-CHzO+, 61, 305 [ M - C H ~ O - ~ H Z O - C ~ H ~ ~ ~ ,  81; FAB MS (+, NaCl+KCltglycerol 
matrix) m/z 535 [M+K]+, 519 [M+Na]+, 371 [M-CgH17]+; IH NMR (CD30D, 500 Mz) 6 0.79 (3H, s, H- 
1.38 (2n, m, H-16), 1.51 ( lH,  H-7p), 1.52 (2H, m, H-15), 1.58 (2H, H-12), 1.64 (lH, H-25), 1.65 (lH, 
H-la), 1.85 (lH, dd, J = 11.9, 3.0 Hz, H-5), 2.00 (lH, dd, J = 13.5, 3.9 Hz, H-IP), 2.18 (lH, H-20), 2.23 
( l a ,  H-7a), 2.48 (IH, H-14), 3.48 (lH, H-81, 3.59 (2H, H-ll), 3.72 (lH, d, J = 11.5 Hz, H-19), 3.80 
. 
18), 0.87 (6H, d, J = 6.5 Hz, H-26, 27), 0.93 (3H, d, J = 6.5 Hz, H-28), 1.06 (3H, d, J = 7.0 Hz, H-21), 
(lH, dd, J = 11.9,3.0 Hz, H-4), 3.82 (lH, H-2), 3.93 (lH, t, J = 3.0 Hz, H-3), 4.28 (lH, H-6), 4.85 (lH, 
d, J = 11.5 Hz, H-19), 5.24 (2H, dd, J = 15.0, 7.5 Hz, H-22), 5.28 (IH, dd, J = 15.0, 8.0 Hz, H-23); 13C 
NMR (CD3OD, 500 Mz) 6 19.0 (C-l8), 19.6 (C-28), 23.5 (C-21), 24.2 (C-26, 27), 25.1 (C-15), 28.1 (C-16), 
31.7 (C-1), 35.7 (C-25), 41.0 (C-8), 41.1 (C-20), 42.2 (C-12), 42.8 (C-7), 44.1 (C-14), 45.8 (C-24), 47.9 
(C-13), 51.3 (C-5), 57.3 (C-lo), 60.5 (C-ll), 64.5 (C-19), 66.2 (C-6), 69.6 (C-4), 69.6 (C-2), 75.4 (C-3), 
135.2 (C-22), 137.7 (C-23), 215.0 (C-9). 
Euryspongiol B5 (10): (6 mg); [ a I 2 l ~  -45" (c 0.002, MeOH); HR EIMS: obsd 468.3092, calcd for 
C26Hq407 468.3087; FAB MS (+, NaCl+glycerol matrix) mlz 491 [M+Na]+; 1H NMR (CD3OD, 250 Mz) 6 
0.78 (3H, S, H-18), 0.97 (6H, d, J = 6.7 Hz, H-25, 26), 1.03 (3H, d, J = 6.8 Hz, H-21), 1.54 (lH, H-7!), 
1.61 (2H, H-12), 1.65 (lH, H-la), 1.83 (lH, dd, J = 11.5, 2.8 Hz, H-5), 2.02 (lH, dd, J = 13.3, 4.6 Hz, 
H-lb), 2.22 (lH, H-74, 2.47 (IH, H-141, 3.43 (lH, H-8), 3.63 (2H, H-ll)% 3.69 (lH, d, J = 11.8 Hz, H- 
H-6), 4.83 (lH, d, J = 11.8 Hz, H-19), 5.29 (2H, m, H-22, 23); 13C NMR (CD30D, 250 Mz) 6 18.1 (C-18), 
19), 3.83 (lH, dd, J = 11.5, 2.6 Hz, H-4), 3.85 (lH, H-2), 3.86 (lH, dd, J = 4.2, 2.6 Hz, H-3), 4.28 (lH, 
22.2 (C-21), 22.9 (C-26, 27), 30.7 (C-I), 32.3 (C-24), 39.3 (C-20), 40.1 (C-8), 41.5 (C-7), 41.5 (C-12), 
43.2 (C-14), 46.7 (C-13), 51.2 ('2-3, 56.1 (C-lo), 59.2 (C-ll), 63.5 (C-19), 65.1 (C-6), 68.2 (C-4), 68.5 
(C-2), 74.3 (C-3), 134.0 (C-23), 137.0 (C-22), 215.0 ((2-9). 
NaBH4Reduction of euryspongiol A l  (1). NaBH4 (2 mg) was added to 1 (12 mg) in MeOH (2 
mL). The misture was stirred 7 h, dilute HCl (10 %, 1 mL) was added, and the solvent was evaporated. 
Purification of the product by preparative HPLC on pBondapak C18 (6:4 MeOWH20) yielded l a  (7.2 mg, Rt 
80.09 min): [o1Iz1D -35" (c 0.001, MeOH); UV Alax (MeOH) 206 nm; HR EIMS: obsd 484.3410, calcd for 
C27H4g07 484.3400; EIMS mlz (%) 484 (I), 454 (3), 422 (4), 355 (j), 338 (9), 320 (lo), 306 (19), 289 
(l l) ,  235 (36), 191 (16), 147 (27), 95 (61), 69 (100); lH NMR (CD30D) 6see Table 2; 13C NMR (CD30D) 6 
see Table 1. 
1. 
i 
Acetylation of l a  to lb .  A mixture of l a  (2 mg) and excess Ac20 in 0.5 ml of dry pyridine was kept 
at room temperature for 12 h, after which removal of the excess reagents in vacuo yielded l b  (4 mg): [a]"D 
-50" (c 0.0001, C12CH2); HR EIMS: obsd 778.4150, calcd for C41H62014 778.4140; 1H NMR (CD3OD, 250 
2.03, 2.07, 2.10, 2.18 and 2.18 (each 3H, s, 01Ac). 
Mz) 60.77 (3H, S, H-18), 0.90 (6H, d, J = 6.6 Hz, H-26, 27), 1.08 (3H, d, J = 6.8 Hz, H-21), 2.01, 2.01, 
Acetylation of 2 to 2a. A crystal of 4-dimethylaminopyridine was left overnight at room temperature 
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in a mixture of 2 (13 mg) and excess of Ac20 in 1 mL of dry pyridine. Removal of excess reagents in vacuo 
afforded the acetylated compound 2a (23 mg): [aI2'~ -29' (c 0.002, C12CH2); UV Amax (C13CH) 244 nm; HR 
EIMS: obsd 736.4029, calcd for C39H60013 736.4034;EIMS mlz  (%) 736 (l), 368 (loo), 353 (24), 326 (4), 
260 (21), 247 (20), 213 (13), 147 (41), 105 (24), 81 (21); 'H NMR (C13CD, 250 Mz) 60.71 (3H, S, H-18), 
0.87 (6H, d, J = 6.5 Hz, H-26, 27), 0.98 (3H, d, J = 6.7 Hz, H-21), 2.00, 2.01, 2.02, 2.03, 2.09, and 2.10 
4 
i. (each 3H, s, OAc), 2.33 (lH, H-lß), 2.48 (lH, m, H-14), 3.37 (lH, m, H-8), 4.11 (2H, m, H-11), 4.57 
(lH, d, J = 12.6 Hz, H-19), 5.13 (lH, m, H-2), 5.38 (lH, d, J = 12.6 Hz, H-19). '9 
Reduction of 2a to 2b. N a B Q  (3 mg) was added to 2a in MeOH (2 mL). The mixture was stirred for 
two hours at O OC, 0.5 % HC1 was added, and the solvent was evaporated. Purification by partition between 
C12CH2 and water and concentration and drying of the C12CH2 eluates gave 23 mg of a product that was 
subjected to preparative HPLC on a p-Bondapak Cl8 column (955 MeOH/H20 at 3 mL.min-1) to yield 2b (1 1 
mg, Rt 5.10 min): [a]"D -87' (c 0.001, C12CH2); HR EIMS: obsd 738.4198, calcd for C39H62013 738.4190; 
'H NMR (CD3OD, 250 Mz) 60.71 (3H, S, H-18), 0.90 (6H, d,  J = 6.5 Hz, H-26, 27),.1.01 (3H, d, J = 6.4 
Hz, H-21), 1.45 (lH, H-la), 1.51 (lH, H-7j?), 1.80 (2H, H-12), 1.91 (lH, dd, J = 10.7, 2.4Hz, H-5), 1.95 
(lH, H-7a), 2.02 (lH, H-8), 2.65 (IH, dd, J = 12.9, 5.2 Hz, H-lj?), 2.33 (lH, H-14), 3.10 (lH, d, J = 10.6 
Hz, H-9), 4.18 (2H, H-Il), 4.43 (lH, d, J = 12.3 Hz, H-19), 4.69 (lH, d, J = 12.3 Hz, H- 19), 5.02 (lH, 
H-6), 5.09 (IH, t, J = 9.4 Hz, H-3), 5.34 (lH, H-2), 5.49 (IH, H-4); 13C NMR (CD30D, 250 Mz) 6 17.6 
(C-lS), 18.5 (C-21), 22.4a (C-26), 2246a(C-27), 45.7 (C-13), 48.6 (C-17), 61.5 (C-ll), 63.2 (C-19), 65.6 
(C-6), 68.6 (C-4), 69.8 (C-2), 75.9 (C-9), 80.6 (C-3), 169.9, 169.9, 170.0, 170.3, 171.2, 171.9 (OAC). 
Acetylation of 2b to 2c: A mixture of 2b (1 mg) and excess Ac20 in 0.3 mL of pyridine was kept at 
room temperature for twelve hours. Removal of excess reagents in vacuo yielded 2c (2 mg): [aIz1~ -50' (c 
0.0002, C12CH2); HR EIMS: obsd 780.4291, calcd for C41H64014 780.4296; 1H NMR (CD30D, 250 Mz) 6 
2.07, 2.09, 2.18 and 2.18 (each 3H, s, OAc). 
0.77 (3H, S, H-18), 0.91 (6H, d, J = 6.6 Hz, H-26, 27), 1.03 (3H, d, J = 6.2 Hz, H-21), 2.01, 2.01, 2.04, 
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